Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Prepaid Assets: 2012-2024

Historic Prepaid Assets for Agios Pharmaceuticals (AGIO) over the last 13 years, with Dec 2024 value amounting to $40.2 million.

  • Agios Pharmaceuticals' Prepaid Assets rose 8.28% to $43.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.2 million, marking a year-over-year increase of 8.28%. This contributed to the annual value of $40.2 million for FY2024, which is 14.69% up from last year.
  • Per Agios Pharmaceuticals' latest filing, its Prepaid Assets stood at $40.2 million for FY2024, which was up 14.69% from $35.0 million recorded in FY2023.
  • Agios Pharmaceuticals' 5-year Prepaid Assets high stood at $40.2 million for FY2024, and its period low was $15.9 million during FY2020.
  • In the last 3 years, Agios Pharmaceuticals' Prepaid Assets had a median value of $39.0 million in 2022 and averaged $38.0 million.
  • As far as peak fluctuations go, Agios Pharmaceuticals' Prepaid Assets slumped by 34.28% in 2020, and later spiked by 150.71% in 2021.
  • Agios Pharmaceuticals' Prepaid Assets (Yearly) stood at $15.9 million in 2020, then surged by 150.71% to $39.8 million in 2021, then decreased by 2.21% to $39.0 million in 2022, then declined by 10.10% to $35.0 million in 2023, then increased by 14.69% to $40.2 million in 2024.